Researchers Use Artificial Intelligence to Determine Extent of Damage in Kidney Disease
Researchers from Boston University School of Medicine have developed a novel AI tool to predict the grade of IFTA for chronic kidney disease.
Read MorePosted by Chris Wolski | May 24, 2021 | Kidney Disease |
Researchers from Boston University School of Medicine have developed a novel AI tool to predict the grade of IFTA for chronic kidney disease.
Read MorePosted by Melanie Hamilton-Basich | May 20, 2021 | Controls, Diabetes & Metabolic Diseases |
The InteliQ Diabetes Control includes three distinct levels that may address the HbA1c precision monitoring needs of a wide range of test methods.
Read MorePosted by Melanie Hamilton-Basich | May 12, 2021 | Sexually Transmitted Diseases |
The University of Chicago Medicine maintained screening volumes by including universal HIV screening alongside COVID-19 testing in its busy emergency department, according to a new report.
Read MorePosted by Melanie Hamilton-Basich | May 6, 2021 | Diabetes & Metabolic Diseases |
Helen Murray Free, a chemist who co-developed the revolutionary dip-and-read diabetes test that simplified diagnosis and inspired other similar testing, has died.
Read MorePosted by Melanie Hamilton-Basich | May 6, 2021 | Covid 19 |
Urine analysis of COVID-19 patients revealed elevated levels of specific biomarkers of the immune system compared to those who were not infected with the coronavirus.
Read More